谷歌Chrome浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

ESAFETY, TOLERABILITY AND PHARMACODYNAMIC ASSESSMENT OF KAN-101, A NOVEL LIVER-TARGETED THERAPY TO INDUCE IMMUNOLOGICAL TOLERANCE TO GLIADIN IN CELIAC DISEASE

Joseph A. Murray,Karen Dunn,Samir Arora,Peter Winkle,Kaela E. Goldstein,Simon Cooper,Rajesh Manchanda,Stephan Kontos, Kristie M. Grebe

GASTROENTEROLOGY（2022）

引用 0|浏览9
暂无评分
关键词
induce immunological tolerance,liver-targeted
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要